Global
Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD,
Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community
Healthcare), By Geography (North America, Europe, Asia-Pacific, South America,
Rest of the World) –Industry Trends and Forecast to 2024
The market of
Global Intra-Uterine Contraceptive Devices Market is expected to reach USD
4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in
the forecast period 2017 to 2024. The new market report contains data for
historic years 2015, the base year of calculation is 2016 and the forecast
period is 2017 to 2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024
The major factors driving
the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing
awareness of contraceptive, increased rate of unplanned pregnancies, rising
number of initiatives undertaken by the private firms, technological
advancements and favourable insurance for IUCD’s.
The Global Intra-Uterine
Contraceptive Devices Market is segmented on the basis of product type, end
user, and geography.
The global
intra-uterine contraceptive devices market is segmented into 2 product
types, namely copper IUCD and hormonal IUCD.
On the basis of end users
the market is segmented into hospitals, gynaecology clinics, and community
healthcare. In 2017, the hospital segment is expected to dominate the market
and is expected to continue this trend till 2024.
Some of the major factors
driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as
growing awareness of contraceptive, increased rate of unplanned pregnancies,
rising number of initiatives undertaken by the private firms, technological
advancements and favourable insurance for IUCD’s.
·
The growing rate of unintended pregnancies has aided the
increase in the adoption of contraceptive methods which is expected to drive
the growth of the IUCD market.
·
The rising number of initiatives to promote the use of intrauterine
contraceptive devices acts as a significant driver for this market.
·
Growing awareness of contraceptive one of the factors
contributing to the growth of the market in Europe.
Based on geography the global
intra-uterine contraceptive devices market is segmented into:
·
North America
·
Europe
·
Asia-Pacific
·
South America
·
Rest of the World
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024
Some
of the major Companies operating in this market are:
·
Bayer AG
·
Teva Pharmaceuticals Industries Ltd.
·
Mona Lisa N.V.
·
DKT International
·
Egemen International
·
Melbea AG
·
Ocon Medical Ltd.
·
Pregna International Limited
·
Medical Engineering Corporation SA
·
SMB Corporation
·
Meril Life Sciences Pvt. Ltd.
·
Medu Scientific Ltd
·
China RH Contraceptives Co., Ltd
·
Sanghai Jolly Medical Education Co.,
Ltd
·
Bernstein Leibhard LLP
·
ZheijangDaji Medical Instruments, Ltd.
·
Nimble International
·
AME Line
·
Technico
·
Cepeo
·
Contraceptivos
·
InjeflexInd And Com Ltd
·
Bersil
·
Amed
Read more about the Global
Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/global-intra-uterine-contraceptive-devices-market-growing-significant-rate-forecast-period-2017-2024/
Table
of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE INTRA-UTERINE
CONTRACEPTIVE DEVICES (IUCD) MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.3. LIMITATION
1.4. MARKETS COVERED
2. RESEARCH
METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE INTRA-UTERINE
CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE
2.2.1. MARKET CRACKDOWN
APPROACH
2.2.2. COMPANY REVENUE AND
MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM
PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM
SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES
MATRIX
2.3. GLOBAL INTRA-UTERINE CONTRACEPTIVE
DEVICESMARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2.1. INCREASED RATE OF
UNPLANNED PREGNANCIES
3.2.2. RISING NUMBER OF INITIATIVES
UNDERTAKEN BY THE PRIVATE FIRMS
3.2.3. FAVOURABLE INSURANCE FOR
IUCD’S
3.2.4. GROWING AWARENESS OF
CONTRACEPTIVE
3.2.5. GROWING FUNDS AND GRANTS
FOR IUCD PRODUCTS
3.2.6. TECHNOLOGICAL
ADVANCEMENTS
3.2. RESTRAINTS
3.2.1. HIGH COST OF TREATMENT
3.2.2. THREAT OF CAUSING PELVIC
INFLAMMOTORY DISEASE (PID)
3.2.3. THREAT CAUSING EPICTAPIC
PREGNANCY
3.2.4. CHANGES IN GOVERNMENT
REGULATIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. HORMONAL IUCD (2013 – 2024)
6.2.1. MARKET VALUE (USD
MILLION)
6.2.2. MARKET VOLUME (UNITS
SOLD)
6.3. COPPER IUCD (2013 – 2024)
6.3.1. MARKET VALUE (USD
MILLION)
6.3.2. MARKET VOLUME (UNITS
SOLD)
7. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
7.1. COUNTRYWISE INTRA-UTERINE
CONTRACEPTIVE DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED
IN THIS CHAPTER BY COUNTRY)
7.1.1. NORTH AMERICA
7.1.1.1. U.S.
7.1.1.2. CANADA
7.1.1.3. MEXICO
7.1.2. EUROPE
7.1.2.1. GERMANY
7.1.2.2. FRANCE
7.1.2.3. U.K.
7.1.2.4. ITALY
7.1.2.5. SPAIN
7.1.2.6. RUSSIA
7.1.2.7. TURKEY
7.1.2.8. BELGIUM
7.1.2.9. NETHERLANDS
7.1.2.10.
SWITZERLAND
7.1.2.11. REST OF EUROPE
7.1.3. ASIA-PACIFIC (APAC)
7.1.3.1. JAPAN
7.1.3.2. CHINA
7.1.3.3. SOUTH KOREA
7.1.3.4. INDIA
7.1.3.5. AUSTRALIA
7.1.3.6. SINGAPORE
7.1.3.7. THAILAND
7.1.3.8. MALAYSIA
7.1.3.9. INDONESIA
7.1.3.10. PHILIPPINES
7.1.3.11. REST OF APAC
7.1.4. LATIN AMERICA
7.1.4.1. BRAZIL
7.1.4.2. COLOMBIA
7.1.4.3. ARGENTINA
7.1.4.4. CHILE
7.1.4.5. ECUADOR
7.1.4.6. URUGUAY
7.1.4.7. PARAGUAY
7.1.4.8. PERU
7.1.4.9. BOLIVIA
7.1.4.10. REST OF LATIN AMERICA
7.1.5. MIDDLE EAST AND AFRICA
7.1.5.1. EGYPT
7.1.5.2. SAUDI ARABIA
7.1.5.3. REST OF SOUTH AMERICA
7.2. KEY PRIMARY INSIGHTS: BY MAJOR
COUNTRIES
8. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
8.1. GLOBAL IUCD MARKET: COMPANY SHARE
ANALYSIS
8.2. U.S.IUCD MARKET: COMPANY SHARE ANALYSIS
8.3. EUROPE IUCD MARKET: COMPANY SHARE
ANALYSIS
8.4. APAC IUCD MARKET: COMPANY SHARE
ANALYSIS
8.5. SOUTH AMERICAIUCD MARKET: COMPANY
SHARE ANALYSIS
8.6. MIDDLE EAST AND AFRICA IUCD MARKET:
COMPANY SHARE ANALYSIS
8.7. MERGERS & ACQUISITIONS
8.8. NEW PRODUCT DEVELOPMENT &
APPROVALS
8.9. EXPANSIONS
8.10. REGULATORY CHANGES
8.11. PARTNERSHIP AND OTHER STRATEGIC
DEVELOPMENTS
9. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.1.1 OVERVIEW
9.1.2 SWOT ANALYSIS
9.1.3 PRODUCT PORTFOLIO
9.1.4 REVENUE ANALYSIS
9.1.5 ANALYSTS VIEW
9.2. DKT INTERNATIONAL
9.2.1 OVERVIEW
9.2.2 SWOT ANALYSIS
9.2.3 PRODUCT PORTFOLIO
9.2.4 REVENUE ANALYSIS
9.2.5 ANALYSTS VIEW
9.3. TEVA PHARMACEUTICALS INDUSTRIES,
LTD
9.3.1 OVERVIEW
9.3.2 SWOT ANALYSIS
9.3.3 PRODUCT PORTFOLIO
9.3.4 REVENUE ANALYSIS
9.3.5 ANALYST VIEW
9.4. ALLERGEN, PLC
9.4.1 OVERVIEW
9.4.2 SWOT ANALYSIS
9.4.3 PRODUCT PORTFOLIO
9.4.4 REVENUE ANALYSIS
9.4.5 ANALYSTS VIEW
9.5. SMB CORPORATION
9.5.1 OVERVIEW
9.5.2 SWOT ANALYSIS
9.5.3 PRODUCT PORTFOLIO
9.5.4 REVENUE ANALYSIS
9.5.5 ANALYSTS VIEW
9.6. ACTAVIS PLC.
9.6.1 OVERVIEW
9.6.2 SWOT ANALYSIS
9.6.3 PRODUCT PORTFOLIO
9.6.4 REVENUE ANALYSIS
9.6.5 ANALYSTS VIEW
9.7 OCON MEDICAL LTD.
9.7.1 OVERVIEW
9.7.2 SWOT ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 REVENUE ANALYSIS
9.7.5 ANALYSTS VIEW
9.8
MONALISA NV
9.8.1 OVERVIEW
9.8.2 SWOT ANALYSIS
9.8.3 PRODUCT PORTFOLIO
9.8.4 REVENUE ANALYSIS
9.8.5 ANALYSTS VIEW
9.9
MEDISAFE DISTRIBUTION, INC.
9.9.1 OVERVIEW
9.9.2 SWOT ANALYSIS
9.9.3 PRODUCT PORTFOLIO
9.9.4 REVENUE ANALYSIS
9.9.5 ANALYSTS VIEW
9.10 MERIL LIFE SCIENCES PVT. LTD.
9.10.1 OVERVIEW
9.10.2
SWOT ANALYSIS
9.10.3 PRODUCT PORTFOLIO
9.10.4 REVENUE ANALYSIS
9.10.5 ANALYSTS VIEW
Browse
Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/
Related
Report
Europe
Injectable Drug Delivery Market – Industry Trends and Forecast to 2024
Europe Injectable Drug
Delivery Market By Type (Devices (Conventional Injection Devices, Self Injection
Devices), Formulations (Conventional
Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By
Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases,
Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage
Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central
Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research
Laboratories, Pharma & Biotech Companies), By Country (Germany, France,
U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherland and rest
of Europe) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/medical-devices/drug-delivery-devices/europe-injectable-drug-delivery-market/
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Ankit
Singh
Data
Bridge Market Research
Tel:
+1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research